Mira Pharmaceuticals Files 8-K: Other Event
Ticker: MIRA · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-event
TL;DR
Mira Pharma filed an 8-K for an 'Other Event' on 6/24/25 - details TBD.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on June 24, 2025, reporting an "Other Event." The filing does not contain specific details about the event, its financial implications, or any associated parties. The company's principal executive offices are located in Miami, Florida.
Why It Matters
This filing indicates a significant event has occurred for Mira Pharmaceuticals, requiring disclosure to investors. However, the lack of detail necessitates further investigation to understand the event's impact.
Risk Assessment
Risk Level: medium — The filing is an 'Other Event' without specific details, creating uncertainty about potential risks or opportunities for investors.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- Miami, Florida (location) — Address of Principal Executive Offices
- Mira1a Therapeutics, Inc. (company) — Former Company Name
FAQ
What specific event is being reported under 'Other Events' in this 8-K filing?
The filing does not specify the nature of the 'Other Event'.
When was the earliest event reported in this filing?
The earliest event reported was on June 24, 2025.
What is the principal executive office address for Mira Pharmaceuticals, Inc.?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What was Mira Pharmaceuticals, Inc.'s former company name?
The former company name was Mira1a Therapeutics, Inc.
What is the Commission File Number for Mira Pharmaceuticals, Inc.?
The Commission File Number is 001-41765.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).